Provided by Tiger Fintech (Singapore) Pte. Ltd.

Hutchison China Meditech

15.10
-0.2400-1.56%
Post-market: 15.100.00000.00%16:04 EDT
Volume:36.92K
Turnover:556.92K
Market Cap:2.63B
PE:75.50
High:15.28
Open:15.10
Low:14.86
Close:15.34
Loading ...

Cytokinetics Announces Launch of EARTH-HCM, a Public Health Education Tool for the Hypertrophic Cardiomyopathy Community

GlobeNewswire
·
20 Mar

Press Release: Intended Retirement of Independent Non-executive Directors and changes of composition of board committees

Dow Jones
·
20 Mar

Oracle Helps Customers Boost Employee Engagement with Strategic Communications and Internal Events

PR Newswire
·
20 Mar

HUTCHMED (China) Ltd (HCM) (Q4 2024) Earnings Call Highlights: Achieving Profitability and ...

GuruFocus.com
·
20 Mar

Hutchmed's Oncology Revenue Hits $271.5 Million, Rising 65% On Fruzaqla Strength

Benzinga
·
20 Mar

Stock Track | Hutchison China Meditech Soars 7.36% on Strong 2025 Outlook and Positive Clinical Trial Results

Stock Track
·
19 Mar

Stock Track | Hutchison China Meditech Soars 5.95% Pre-market on Strong 2025 Guidance and Positive Clinical Trial Results

Stock Track
·
19 Mar

Sector Update: Health Care Stocks Steady to Higher Pre-Bell Wednesday

MT Newswires Live
·
19 Mar

Here’s What Lifted Paycom Software (PAYC) Stock up More Than 20%

Insider Monkey
·
19 Mar

Hutchmed's 2024 Earnings, Revenue Fall

MT Newswires Live
·
19 Mar

Hutchmed sees FY25 Oncology/Immunology revenue $350M-$450M

TIPRANKS
·
19 Mar

Hutchmed reports FY24 EPS 22c vs. 59c last year

TIPRANKS
·
19 Mar

HUTCHMED Projects 2025 Oncology Revenue Between $350M–$450M, Backed By Strong Balance Sheet

Benzinga
·
19 Mar

HUTCHMED (China) FY 2024 GAAP EPS $0.22 Down From $0.58 YoY, Sales $630.20M Down From $838.00M YoY

Benzinga
·
19 Mar

Hutchmed/Innovent update on Phase 2/3 study of Fruquintinib+Sintilimab

TIPRANKS
·
19 Mar

HUTCHMED and Innovent Jointly Announce that the FRUSICA-2 Phase II/III Study of Fruquintinib and Sintilimab Combination Has Met its Primary Endpoint in Advanced Renal Cell Carcinoma in China

GlobeNewswire
·
19 Mar

Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire
·
19 Mar

Paychex Survey Finds AI is Empowering Small Businesses, with 72% Feeling Positive

Business Wire
·
18 Mar

Whatfix Enters Federal Sector, Empowering US Army PEO-Enterprise with AI-Powered Digital Adoption Solutions for the World's Largest Personnel & Pay System

PR Newswire
·
18 Mar

Cytokinetics Announces Five Presentations at the American College of Cardiology Annual Scientific Session & Expo

GlobeNewswire
·
17 Mar